Benefits Of Magtein In Collegiate Athletes At SupplySide Global

New research on benefits of Magtein® in collegiate athletes spotlighted at SupplySide Global
Credit: PeopleImages/Shutterstock

USA | ThreoTech, LLC, the exclusive global supplier of Magtein, announced that new findings on Magtein in collegiate athletes will be spotlighted at SupplySide Global.

The breakfast briefing, "Magnesium L-Threonate (Magtein) in Collegiate Athletes: Lessons from the UCLA Sports Medicine Study," will be led by Dr Jeremy Swisher, MD, UCLA Health Sciences Assistant Clinical Professor and sports medicine physician.

Magtein is the patented, proprietary form of magnesium that supports healthy magnesium levels in the brain by facilitating magnesium delivery across the blood–brain barrier and into brain neurons, helping maintain optimal magnesium availability where it is needed.

To date, five peer-reviewed, randomised, double-blind, placebo-controlled human trials (RCTs) on Magtein have been published across three countries: the United States, China, and Australia. These results have demonstrated improvements in brain health, cognitive vitality, and sleep quality across diverse adult populations.

Additional human RCTs are underway, including studies conducted by independent research groups, further expanding the clinical evidence base for Magtein.

As the Magtein research base has grown, it has become an increasingly trusted magnesium form for studying brain magnesium, cognition, and healthy brain function across both preclinical and human research, with the evidence base now spanning more than 50 peer-reviewed scientific publications.

Researchers have now carried out the first study specifically exploring Magtein’s benefits in athletes. This randomised, placebo-controlled study in UCLA college athletes examined whether the sleep benefits previously demonstrated with Magtein extend to an athletic population, while also assessing recovery and physical performance over four weeks.

At SupplySide Global, ThreoTech will hold a breakfast briefing to discuss the research recently carried out by Dr Swisher's group at UCLA. These preliminary findings were first presented as a poster at the American Medical Society for Sports Medicine (AMSSM) Annual Meeting in April 2026, and full results are scheduled to be published in a peer-reviewed journal later this year.

More events & expos here